Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols

References

• Dieckmann KP, Loy V. Prevalence of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell neoplasms. J Clin Oncol 1996;14:3126–32.
   PubMed Web of Science ®Google Scholar
• von der Maase H, Rorth M, Walbom-Jorgensen S, Sorensen BL, Christophersen IS, Hald T, et al. Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: Study of 27 cases in 500 patients. Br Med J (Clin Res Ed) 1986;293:1398–401.
   PubMed Web of Science ®Google Scholar
• Harland SJ, Cook PA, Fossa SD, Horwich A, Mead GM, Parkinson MC, et al. Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: Defining a high risk group. J Urol 1998;160:1353–7.
   PubMed Web of Science ®Google Scholar
• Dieckmann KP, Skakkebaek NE. Carcinoma in situ of the testis: Review of biological and clinical features. Int J Cancer 1999;83:815–22.
   PubMed Web of Science ®Google Scholar
• Brabrand S, Fossa SD, Cvancarova M, Axcrona U, Lehne G. Probability of metachronous testicular cancer in patients with biopsy-proven intratubular germ cell neoplasia depends on first-time treatment of germ cell cancer. J Clin Oncol 2012;30:4004–10.
   PubMed Web of Science ®Google Scholar
• Bokemeyer C, Schmoll HJ, Schoffski P, Harstrick A, Bading M, Poliwoda H. Bilateral testicular tumours: Prevalence and clinical implications. Eur J Cancer 1993;29A:874–6.
   PubMed Web of Science ®Google Scholar
• Osterlind A, Berthelsen JG, Abildgaard N, Hansen SO, Hjalgrim H, Johansen B, et al. Risk of bilateral testicular germ cell cancer in Denmark: 1960–1984. J Natl Cancer Inst 1991;83:1391–5.
   PubMed Web of Science ®Google Scholar
• Andreassen KE, Grotmol T, Cvancarova MS, Johannesen TB, Fossa SD. Risk of metachronous contralateral testicular germ cell tumors: A population-based study of 7,102 Norwegian patients (1953–2007). Int J Cancer 2011;129:2867–74.
   PubMed Web of Science ®Google Scholar
• Souchon R, Gertenbach U, Dieckmann KP, Hahn E, Ruwe M, Stambolis C, et al. Contralateral testicular cancer in spite of TIN-negative double biopsies and interval cisplatin chemotherapy. Strahlenther Onkol 2006;182:289–92.
   PubMed Web of Science ®Google Scholar
• Dieckmann KP, Loy V. False-negative biopsies for the diagnosis of testicular intraepithelial neoplasia (TIN) – an update. Eur Urol 2003;43:516–21.
   PubMed Web of Science ®Google Scholar
• Cancer Registry of Norway. Cancer in Norway 2010 – Cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway; 2012.
   Google Scholar
• Socialstyrelsen. Cancer incidence in Sweden 2011. Stockholm: Socialstyrelsen; 2012.
   Google Scholar
• Tandstad T, Cohn-Cedermark G, Dahl O, Stierner U, Cavallin-Stahl E, Bremnes RM, et al. Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study. Ann Oncol 2010;21:1858–63.
   PubMed Web of Science ®Google Scholar
• Tandstad T, Dahl O, Cohn-Cedermark G, Cavallin-Stahl E, Stierner U, Solberg A, et al. Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: The SWENOTECA management program. J Clin Oncol 2009;27:2122–8.
   PubMed Web of Science ®Google Scholar
• Fossa SD, Chen J, Schonfeld SJ, McGlynn KA, McMaster ML, Gail MH, et al. Risk of contralateral testicular cancer: A population-based study of 29,515 U.S. men. J Natl Cancer Inst 2005;97:1056–66.
   PubMed Web of Science ®Google Scholar
• Albers P, Goll A, Bierhoff E, Schoeneich G, Muller SC. Clinical course and histopathologic risk factor assessment in patients with bilateral testicular germ cell tumors. Urology 1999;54:714–8.
   PubMed Web of Science ®Google Scholar
• Coogan CL, Foster RS, Simmons GR, Tognoni PG, Roth BJ, Donohue JP. Bilateral testicular tumors: Management and outcome in 21 patients. Cancer 1998;83:547–52.
   PubMed Web of Science ®Google Scholar
• Dieckmann KP, Kulejewski M, Pichlmeier U, Loy V. Diagnosis of contralateral testicular intraepithelial neoplasia (TIN) in patients with testicular germ cell cancer: Systematic two-site biopsies are more sensitive than a single random biopsy. Eur Urol 2007;51:175–83; discussion 83–5.
   PubMed Web of Science ®Google Scholar
• Kliesch S, Thomaidis T, Schutte B, Puhse G, Kater B, Roth S, et al. Update on the diagnostic safety for detection of testicular intraepithelial neoplasia (TIN). APMIS 2003;111:70–4; discussion 5.
   PubMed Web of Science ®Google Scholar
• Oliver RT, Mead GM, Rustin GJ, Joffe JK, Aass N, Coleman R, et al. Randomized trial of carboplatin versus radiotherapy for stage I seminoma: Mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 Study (ISRCTN27163214). J Clin Oncol 2011;29: 957–62.
   PubMed Web of Science ®Google Scholar
• Powles T, Robinson D, Shamash J, Moller H, Tranter N, Oliver T. The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis. Ann Oncol 2008;19:443–7.
   PubMed Web of Science ®Google Scholar
• Dieckmann KP, Heinemann V, Frey U, Pichlmeier U, German Testicular Cancer Study G. How harmful is contralateral testicular biopsy? – an analysis of serial imaging studies and a prospective evaluation of surgical complications. Eur Urol 2005;48:662–72.
   PubMed Web of Science ®Google Scholar
• Petersen PM, Giwercman A, Hansen SW, Berthelsen JG, Daugaard G, Rorth M, et al. Impaired testicular function in patients with carcinoma-in-situ of the testis. J Clin Oncol 1999;17:173–9.
   PubMed Web of Science ®Google Scholar
• Petersen PM, Giwercman A, Daugaard G, Rorth M, Petersen JH, Skakkeaek NE, et al. Effect of graded testicular doses of radiotherapy in patients treated for carcinoma- in-situ in the testis. J Clin Oncol 2002;20:1537–43.
   PubMed Web of Science ®Google Scholar
• Dotsch M, Brauers A, Buttner R, Nolte-Ernsting C, Eble MJ, Jakse G. Malignant germ cell tumor of the contralateral testis after radiotherapy for testicular intraepithelial neoplasia. J Urol 2000;164:452–3.
   PubMed Web of Science ®Google Scholar